| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penile Neoplasms | 12 | 2014 | 161 | 2.280 |
Why?
|
| Urinary Diversion | 26 | 2011 | 134 | 1.940 |
Why?
|
| Prostate | 14 | 2013 | 1770 | 0.890 |
Why?
|
| Prostatic Neoplasms | 32 | 2018 | 11118 | 0.840 |
Why?
|
| Ureteral Obstruction | 9 | 2011 | 293 | 0.760 |
Why?
|
| Penis | 6 | 2014 | 212 | 0.710 |
Why?
|
| Prostatectomy | 14 | 2018 | 1824 | 0.700 |
Why?
|
| Ileum | 15 | 2009 | 557 | 0.670 |
Why?
|
| Kidney Neoplasms | 17 | 2012 | 4248 | 0.650 |
Why?
|
| Carcinoma, Renal Cell | 11 | 2012 | 3163 | 0.530 |
Why?
|
| Prostate-Specific Antigen | 14 | 2018 | 2469 | 0.510 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2014 | 4021 | 0.500 |
Why?
|
| Carcinoma, Transitional Cell | 8 | 2010 | 782 | 0.500 |
Why?
|
| Lymph Node Excision | 8 | 2005 | 1271 | 0.490 |
Why?
|
| Urinary Bladder Neoplasms | 10 | 2015 | 2223 | 0.490 |
Why?
|
| Perineum | 2 | 2013 | 208 | 0.430 |
Why?
|
| Cystectomy | 3 | 2015 | 634 | 0.430 |
Why?
|
| Carcinoma, Small Cell | 1 | 2015 | 420 | 0.410 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 1999 | 202 | 0.410 |
Why?
|
| Ureteral Neoplasms | 2 | 2010 | 106 | 0.390 |
Why?
|
| Urologic Surgical Procedures, Male | 2 | 2014 | 78 | 0.370 |
Why?
|
| Catheter Ablation | 8 | 2012 | 2752 | 0.360 |
Why?
|
| Urinary Reservoirs, Continent | 3 | 1999 | 29 | 0.360 |
Why?
|
| Kidney | 21 | 2006 | 7049 | 0.350 |
Why?
|
| Biopsy | 10 | 2018 | 6766 | 0.340 |
Why?
|
| Water-Electrolyte Imbalance | 3 | 2004 | 109 | 0.330 |
Why?
|
| Nephrectomy | 6 | 2010 | 937 | 0.320 |
Why?
|
| Acidosis | 9 | 1992 | 268 | 0.320 |
Why?
|
| Lithotripsy | 3 | 2007 | 140 | 0.310 |
Why?
|
| Neoplasm Staging | 16 | 2015 | 11106 | 0.300 |
Why?
|
| Urology | 3 | 1998 | 400 | 0.300 |
Why?
|
| Colon, Sigmoid | 4 | 2005 | 124 | 0.300 |
Why?
|
| Genital Diseases, Male | 3 | 2003 | 83 | 0.290 |
Why?
|
| Oxides | 2 | 2008 | 401 | 0.290 |
Why?
|
| Fibroblast Growth Factors | 4 | 2004 | 867 | 0.280 |
Why?
|
| Growth Substances | 2 | 1999 | 768 | 0.280 |
Why?
|
| Hospitals, General | 1 | 2010 | 798 | 0.260 |
Why?
|
| Glomerular Filtration Rate | 5 | 2011 | 2176 | 0.260 |
Why?
|
| Acid-Base Imbalance | 2 | 2004 | 41 | 0.260 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 791 | 0.260 |
Why?
|
| Cystatins | 1 | 2005 | 55 | 0.260 |
Why?
|
| Surgical Flaps | 3 | 2005 | 1671 | 0.250 |
Why?
|
| Acute Kidney Injury | 4 | 2005 | 1924 | 0.250 |
Why?
|
| Lymphatic Metastasis | 9 | 2015 | 2914 | 0.250 |
Why?
|
| Kidney Diseases | 8 | 2010 | 2092 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 10 | 2015 | 3589 | 0.250 |
Why?
|
| Receptors, Androgen | 3 | 2008 | 1079 | 0.240 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 809 | 0.240 |
Why?
|
| Urine | 3 | 1999 | 362 | 0.230 |
Why?
|
| Magnetic Resonance Spectroscopy | 6 | 2018 | 3769 | 0.220 |
Why?
|
| Neoplasm Recurrence, Local | 11 | 2018 | 9277 | 0.210 |
Why?
|
| Electrolytes | 5 | 1991 | 274 | 0.210 |
Why?
|
| Chlorides | 6 | 1995 | 665 | 0.200 |
Why?
|
| Lymphedema | 2 | 2013 | 525 | 0.200 |
Why?
|
| Ureter | 7 | 2011 | 367 | 0.200 |
Why?
|
| Male | 97 | 2018 | 360736 | 0.200 |
Why?
|
| Urinary Bladder Diseases | 3 | 1994 | 167 | 0.190 |
Why?
|
| Ammonia | 5 | 2004 | 237 | 0.190 |
Why?
|
| Kidney Function Tests | 6 | 2005 | 678 | 0.190 |
Why?
|
| Humans | 131 | 2018 | 761423 | 0.190 |
Why?
|
| Kidney Calculi | 1 | 2005 | 463 | 0.190 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2001 | 191 | 0.180 |
Why?
|
| Metabolomics | 4 | 2018 | 1657 | 0.180 |
Why?
|
| Intestines | 6 | 2011 | 1909 | 0.180 |
Why?
|
| Iron | 2 | 2008 | 1792 | 0.180 |
Why?
|
| Disease-Free Survival | 8 | 2015 | 6814 | 0.180 |
Why?
|
| Groin | 3 | 2005 | 106 | 0.180 |
Why?
|
| Erectile Dysfunction | 4 | 2008 | 444 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 621 | 0.170 |
Why?
|
| Keratinocytes | 2 | 2001 | 790 | 0.170 |
Why?
|
| Vagina | 1 | 2005 | 838 | 0.170 |
Why?
|
| Stromal Cells | 3 | 1999 | 1330 | 0.160 |
Why?
|
| Prostatic Hyperplasia | 4 | 2018 | 521 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2010 | 2523 | 0.160 |
Why?
|
| Shock, Septic | 1 | 2005 | 768 | 0.160 |
Why?
|
| Kidney Pelvis | 4 | 2009 | 186 | 0.160 |
Why?
|
| Image Enhancement | 2 | 2008 | 2884 | 0.150 |
Why?
|
| Colon | 10 | 2005 | 1792 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2005 | 1496 | 0.150 |
Why?
|
| Metabolic Diseases | 1 | 2004 | 681 | 0.150 |
Why?
|
| Middle Aged | 53 | 2018 | 220826 | 0.150 |
Why?
|
| Urologic Neoplasms | 4 | 2013 | 314 | 0.150 |
Why?
|
| Urinary Bladder | 6 | 2014 | 1152 | 0.140 |
Why?
|
| Fibroblast Growth Factor 7 | 4 | 2004 | 59 | 0.140 |
Why?
|
| Lymph Nodes | 2 | 2005 | 3466 | 0.140 |
Why?
|
| Urologic Diseases | 2 | 2011 | 247 | 0.140 |
Why?
|
| Aged | 42 | 2018 | 169235 | 0.140 |
Why?
|
| Minerals | 2 | 1988 | 283 | 0.140 |
Why?
|
| Potassium | 6 | 1995 | 1311 | 0.140 |
Why?
|
| Adenocarcinoma | 7 | 2013 | 6339 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 1876 | 0.130 |
Why?
|
| Contrast Media | 3 | 2008 | 5311 | 0.130 |
Why?
|
| Hydrogen | 2 | 1995 | 172 | 0.130 |
Why?
|
| Intestinal Mucosa | 4 | 1995 | 3030 | 0.120 |
Why?
|
| Time Factors | 17 | 2015 | 39975 | 0.120 |
Why?
|
| Cystitis | 2 | 2014 | 95 | 0.120 |
Why?
|
| Intestinal Absorption | 7 | 1992 | 400 | 0.120 |
Why?
|
| Gangrene | 2 | 2013 | 91 | 0.120 |
Why?
|
| Proteus mirabilis | 1 | 2014 | 24 | 0.120 |
Why?
|
| Follow-Up Studies | 17 | 2018 | 39117 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5794 | 0.110 |
Why?
|
| Telangiectasis | 1 | 2014 | 78 | 0.110 |
Why?
|
| Cell Division | 4 | 2004 | 4466 | 0.110 |
Why?
|
| Cecum | 2 | 1992 | 233 | 0.110 |
Why?
|
| Specialty Boards | 1 | 1996 | 235 | 0.110 |
Why?
|
| Rats, Inbred Strains | 8 | 1992 | 2089 | 0.110 |
Why?
|
| Urethra | 3 | 2004 | 405 | 0.110 |
Why?
|
| Lymphangitis | 1 | 2013 | 15 | 0.110 |
Why?
|
| Sensitivity and Specificity | 6 | 2012 | 14664 | 0.110 |
Why?
|
| Disease Progression | 7 | 2018 | 13502 | 0.110 |
Why?
|
| Diuresis | 4 | 1986 | 106 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2014 | 20556 | 0.110 |
Why?
|
| Adult | 35 | 2018 | 221148 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 1998 | 823 | 0.110 |
Why?
|
| Bile | 2 | 1992 | 298 | 0.110 |
Why?
|
| Rats | 20 | 2008 | 23742 | 0.100 |
Why?
|
| Prognosis | 11 | 2013 | 29620 | 0.100 |
Why?
|
| Urography | 3 | 2010 | 316 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 6479 | 0.100 |
Why?
|
| Survival Rate | 9 | 2013 | 12720 | 0.100 |
Why?
|
| Wound Healing | 3 | 2003 | 2803 | 0.100 |
Why?
|
| Certification | 1 | 1996 | 418 | 0.100 |
Why?
|
| Mathematics | 3 | 2010 | 707 | 0.100 |
Why?
|
| Laser Coagulation | 1 | 2014 | 330 | 0.100 |
Why?
|
| Lasers, Solid-State | 1 | 2014 | 175 | 0.100 |
Why?
|
| Citric Acid | 1 | 2012 | 123 | 0.100 |
Why?
|
| Urethral Neoplasms | 2 | 2004 | 37 | 0.100 |
Why?
|
| Retrospective Studies | 16 | 2018 | 80582 | 0.100 |
Why?
|
| Sodium | 9 | 1995 | 1588 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2005 | 5291 | 0.090 |
Why?
|
| Renal Circulation | 3 | 1988 | 291 | 0.090 |
Why?
|
| Urinary Calculi | 2 | 2007 | 90 | 0.090 |
Why?
|
| Androgens | 1 | 1998 | 1286 | 0.090 |
Why?
|
| Urination | 2 | 2010 | 203 | 0.090 |
Why?
|
| Watchful Waiting | 1 | 2015 | 491 | 0.090 |
Why?
|
| Acetyltransferases | 2 | 2010 | 231 | 0.090 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 1991 | 42 | 0.090 |
Why?
|
| Body Water | 1 | 1991 | 340 | 0.090 |
Why?
|
| Treatment Outcome | 10 | 2015 | 64651 | 0.090 |
Why?
|
| Ornithine Decarboxylase | 1 | 2010 | 63 | 0.090 |
Why?
|
| Spermine | 1 | 2010 | 70 | 0.090 |
Why?
|
| Reoperation | 4 | 2012 | 4303 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2015 | 58956 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2018 | 6231 | 0.090 |
Why?
|
| Dogs | 9 | 1999 | 3839 | 0.090 |
Why?
|
| Hematuria | 2 | 2010 | 233 | 0.080 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2013 | 175 | 0.080 |
Why?
|
| Fibroblast Growth Factor 10 | 2 | 1999 | 31 | 0.080 |
Why?
|
| Surgery, Plastic | 2 | 1989 | 643 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 1784 | 0.080 |
Why?
|
| Pelvic Exenteration | 1 | 1989 | 21 | 0.080 |
Why?
|
| Cystatin B | 1 | 2009 | 12 | 0.080 |
Why?
|
| Postoperative Complications | 12 | 2009 | 15650 | 0.080 |
Why?
|
| Skin | 1 | 2003 | 4481 | 0.080 |
Why?
|
| Abdomen, Acute | 2 | 1988 | 122 | 0.080 |
Why?
|
| Chlorpromazine | 2 | 1985 | 111 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2015 | 3514 | 0.080 |
Why?
|
| Phentolamine | 1 | 1988 | 102 | 0.080 |
Why?
|
| Papaverine | 1 | 1988 | 45 | 0.080 |
Why?
|
| Magnesium | 2 | 1989 | 808 | 0.080 |
Why?
|
| Gene Amplification | 1 | 2013 | 1088 | 0.080 |
Why?
|
| Treatment Failure | 2 | 2011 | 2642 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2010 | 12796 | 0.080 |
Why?
|
| Penile Erection | 1 | 1988 | 100 | 0.070 |
Why?
|
| Ferrosoferric Oxide | 2 | 2008 | 348 | 0.070 |
Why?
|
| Bone and Bones | 2 | 1988 | 2568 | 0.070 |
Why?
|
| Sulfates | 1 | 1989 | 380 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 12970 | 0.070 |
Why?
|
| Magnetite Nanoparticles | 2 | 2008 | 318 | 0.070 |
Why?
|
| Dextrans | 2 | 2008 | 574 | 0.070 |
Why?
|
| Propylene Glycols | 1 | 2007 | 91 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2009 | 36423 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2010 | 546 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1189 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2001 | 18964 | 0.070 |
Why?
|
| Urogenital Neoplasms | 1 | 2008 | 131 | 0.070 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2010 | 495 | 0.070 |
Why?
|
| Biological Transport | 6 | 1992 | 2092 | 0.070 |
Why?
|
| Laparoscopy | 2 | 2009 | 2035 | 0.070 |
Why?
|
| Lymphangioma | 1 | 1986 | 61 | 0.070 |
Why?
|
| Osmolar Concentration | 6 | 1986 | 660 | 0.070 |
Why?
|
| General Surgery | 1 | 1997 | 1692 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2004 | 1520 | 0.070 |
Why?
|
| Gastric Mucosa | 2 | 2004 | 604 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 1277 | 0.060 |
Why?
|
| Microvilli | 2 | 1997 | 234 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 2 | 1998 | 1626 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 15262 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 695 | 0.060 |
Why?
|
| Boston | 3 | 2015 | 9330 | 0.060 |
Why?
|
| Pyelonephritis | 1 | 1985 | 75 | 0.060 |
Why?
|
| Immunohistochemistry | 5 | 2008 | 11073 | 0.060 |
Why?
|
| Epithelial Cells | 3 | 2004 | 3667 | 0.060 |
Why?
|
| Reflex, Abnormal | 1 | 2005 | 83 | 0.060 |
Why?
|
| Creatinine | 4 | 2005 | 1899 | 0.060 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 241 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 8529 | 0.060 |
Why?
|
| Salvage Therapy | 1 | 2011 | 1264 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1995 | 2498 | 0.060 |
Why?
|
| Ketorolac | 1 | 2005 | 94 | 0.060 |
Why?
|
| Scrotum | 2 | 1983 | 116 | 0.060 |
Why?
|
| Carcinoma | 3 | 2013 | 2330 | 0.060 |
Why?
|
| Hydronephrosis | 3 | 1981 | 271 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 20093 | 0.060 |
Why?
|
| Animals | 33 | 2011 | 168441 | 0.060 |
Why?
|
| Niacin | 1 | 1985 | 118 | 0.060 |
Why?
|
| Palladium | 1 | 2004 | 67 | 0.060 |
Why?
|
| Amiloride | 2 | 1995 | 116 | 0.060 |
Why?
|
| Cosmetics | 1 | 2005 | 102 | 0.060 |
Why?
|
| Cystatin C | 1 | 2005 | 269 | 0.060 |
Why?
|
| Abscess | 2 | 1985 | 606 | 0.060 |
Why?
|
| Nanostructures | 2 | 2005 | 551 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 2008 | 489 | 0.050 |
Why?
|
| Genital Neoplasms, Male | 1 | 2003 | 68 | 0.050 |
Why?
|
| Risk | 2 | 2005 | 9612 | 0.050 |
Why?
|
| Radioisotopes | 1 | 2004 | 499 | 0.050 |
Why?
|
| Risk Factors | 7 | 2015 | 74167 | 0.050 |
Why?
|
| Female | 43 | 2015 | 392581 | 0.050 |
Why?
|
| Urinary Tract Infections | 3 | 1985 | 803 | 0.050 |
Why?
|
| Clinical Competence | 1 | 1998 | 4793 | 0.050 |
Why?
|
| Leuprolide | 1 | 2004 | 312 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2008 | 795 | 0.050 |
Why?
|
| Liver | 6 | 2004 | 7532 | 0.050 |
Why?
|
| Activins | 1 | 2004 | 210 | 0.050 |
Why?
|
| Burns | 4 | 1979 | 1882 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 2012 | 1975 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2008 | 8179 | 0.050 |
Why?
|
| Jejunum | 1 | 2004 | 472 | 0.050 |
Why?
|
| Neoplasm Metastasis | 4 | 2008 | 4912 | 0.050 |
Why?
|
| Stomach | 2 | 2004 | 696 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 1988 | 1023 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2015 | 41446 | 0.050 |
Why?
|
| Indomethacin | 1 | 1982 | 326 | 0.050 |
Why?
|
| Recovery of Function | 2 | 2009 | 2977 | 0.050 |
Why?
|
| Captopril | 1 | 1982 | 265 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2006 | 5970 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 12456 | 0.050 |
Why?
|
| Acid-Base Equilibrium | 3 | 1991 | 181 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1188 | 0.050 |
Why?
|
| Epithelium | 2 | 2012 | 1603 | 0.050 |
Why?
|
| Flutamide | 1 | 2001 | 95 | 0.050 |
Why?
|
| Uremia | 2 | 1991 | 201 | 0.050 |
Why?
|
| Proline | 1 | 1982 | 457 | 0.040 |
Why?
|
| Testicular Neoplasms | 2 | 2005 | 799 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 409 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 1725 | 0.040 |
Why?
|
| Urodynamics | 3 | 1987 | 346 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2005 | 1186 | 0.040 |
Why?
|
| Temperature | 1 | 2007 | 2228 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2001 | 214 | 0.040 |
Why?
|
| Calcium | 3 | 1989 | 5727 | 0.040 |
Why?
|
| Remission Induction | 1 | 2005 | 2395 | 0.040 |
Why?
|
| Methods | 3 | 1992 | 1074 | 0.040 |
Why?
|
| Endotoxins | 2 | 1978 | 521 | 0.040 |
Why?
|
| Heparin | 1 | 1986 | 1632 | 0.040 |
Why?
|
| Forecasting | 2 | 1998 | 2928 | 0.040 |
Why?
|
| Syndrome | 1 | 2005 | 3268 | 0.040 |
Why?
|
| Urinary Catheterization | 2 | 1992 | 193 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4575 | 0.040 |
Why?
|
| Bone Diseases | 2 | 1992 | 418 | 0.040 |
Why?
|
| Bicarbonates | 3 | 1991 | 292 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 1998 | 222 | 0.040 |
Why?
|
| Keratins | 1 | 1999 | 497 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 420 | 0.040 |
Why?
|
| Teaching Materials | 1 | 1998 | 84 | 0.040 |
Why?
|
| Vena Cava, Inferior | 2 | 1991 | 459 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 1980 | 358 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 522 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1999 | 1060 | 0.040 |
Why?
|
| Glucose | 6 | 1992 | 4347 | 0.040 |
Why?
|
| Organ Size | 3 | 2011 | 2254 | 0.040 |
Why?
|
| Membranes | 1 | 1977 | 165 | 0.040 |
Why?
|
| Sodium Bicarbonate | 2 | 1988 | 60 | 0.030 |
Why?
|
| Principal Component Analysis | 2 | 2010 | 942 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2004 | 1223 | 0.030 |
Why?
|
| Kallikreins | 1 | 2018 | 220 | 0.030 |
Why?
|
| Radiography | 3 | 2006 | 6966 | 0.030 |
Why?
|
| Inulin | 3 | 1985 | 68 | 0.030 |
Why?
|
| Mucous Membrane | 2 | 2014 | 657 | 0.030 |
Why?
|
| Culture Media | 1 | 1998 | 896 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 2000 | 417 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 2 | 1986 | 2471 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2008 | 1955 | 0.030 |
Why?
|
| Acridine Orange | 1 | 1995 | 28 | 0.030 |
Why?
|
| Nitrogen | 1 | 1977 | 348 | 0.030 |
Why?
|
| Parenteral Nutrition | 2 | 1977 | 659 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 1976 | 139 | 0.030 |
Why?
|
| Kidney Tubules | 3 | 1990 | 449 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 18247 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1997 | 563 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3530 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1981 | 2218 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2273 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12058 | 0.030 |
Why?
|
| Bumetanide | 1 | 1995 | 98 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6032 | 0.030 |
Why?
|
| Lung | 1 | 2014 | 9995 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2000 | 1230 | 0.030 |
Why?
|
| History, 19th Century | 1 | 1997 | 720 | 0.030 |
Why?
|
| Vacuoles | 1 | 1995 | 228 | 0.030 |
Why?
|
| Cause of Death | 1 | 2005 | 3684 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 9320 | 0.030 |
Why?
|
| Ion Transport | 1 | 1995 | 319 | 0.030 |
Why?
|
| Age Factors | 3 | 2011 | 18400 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10441 | 0.030 |
Why?
|
| Carcinoid Tumor | 1 | 1976 | 224 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2011 | 4686 | 0.030 |
Why?
|
| Technetium | 2 | 1986 | 322 | 0.030 |
Why?
|
| Child | 9 | 2007 | 80162 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2000 | 1092 | 0.030 |
Why?
|
| Prostatic Diseases | 2 | 1986 | 57 | 0.030 |
Why?
|
| Radiography, Interventional | 3 | 2005 | 1121 | 0.030 |
Why?
|
| Length of Stay | 2 | 2005 | 6422 | 0.030 |
Why?
|
| Fluorescence | 1 | 1995 | 756 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1980 | 1116 | 0.030 |
Why?
|
| Ammonium Chloride | 2 | 1991 | 72 | 0.030 |
Why?
|
| Ion Exchange | 1 | 1972 | 16 | 0.030 |
Why?
|
| Barium | 1 | 1992 | 62 | 0.030 |
Why?
|
| Peritonitis | 1 | 1975 | 368 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1972 | 42 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2001 | 1410 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2851 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2001 | 4124 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1999 | 5036 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 2529 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 1972 | 100 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2005 | 3744 | 0.020 |
Why?
|
| Urease | 1 | 1991 | 39 | 0.020 |
Why?
|
| Furosemide | 1 | 1992 | 170 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3576 | 0.020 |
Why?
|
| Intestinal Fistula | 1 | 1972 | 142 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1992 | 251 | 0.020 |
Why?
|
| Gastric Juice | 1 | 1971 | 59 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1972 | 306 | 0.020 |
Why?
|
| Adolescent | 9 | 2005 | 88313 | 0.020 |
Why?
|
| Kidney Concentrating Ability | 2 | 1991 | 34 | 0.020 |
Why?
|
| Metabolome | 1 | 2018 | 987 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 1992 | 384 | 0.020 |
Why?
|
| Anastomosis, Surgical | 2 | 2011 | 982 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1997 | 1205 | 0.020 |
Why?
|
| Meningomyelocele | 1 | 1992 | 171 | 0.020 |
Why?
|
| Hematoma | 1 | 1975 | 768 | 0.020 |
Why?
|
| Iodobenzoates | 1 | 1990 | 10 | 0.020 |
Why?
|
| Ribs | 1 | 2012 | 252 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 1991 | 170 | 0.020 |
Why?
|
| Kidney Tubules, Distal | 3 | 1976 | 42 | 0.020 |
Why?
|
| Growth | 1 | 1992 | 365 | 0.020 |
Why?
|
| Triiodobenzoic Acids | 1 | 1990 | 123 | 0.020 |
Why?
|
| Prednisolone | 1 | 1991 | 326 | 0.020 |
Why?
|
| Cell Membrane | 2 | 1995 | 3687 | 0.020 |
Why?
|
| Ultrasonics | 1 | 1990 | 207 | 0.020 |
Why?
|
| Intestinal Neoplasms | 1 | 1992 | 312 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2009 | 54415 | 0.020 |
Why?
|
| Recurrence | 4 | 2009 | 8469 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1997 | 2769 | 0.020 |
Why?
|
| Urea | 2 | 1985 | 444 | 0.020 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1991 | 161 | 0.020 |
Why?
|
| Azathioprine | 1 | 1991 | 354 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2004 | 5305 | 0.020 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1989 | 50 | 0.020 |
Why?
|
| Sigmoid Neoplasms | 1 | 1989 | 54 | 0.020 |
Why?
|
| Educational Measurement | 1 | 1996 | 1254 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2008 | 12125 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 10203 | 0.020 |
Why?
|
| Femoral Nerve | 1 | 2008 | 42 | 0.020 |
Why?
|
| Massachusetts | 2 | 2000 | 8832 | 0.020 |
Why?
|
| Linear Models | 1 | 1998 | 5869 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 59207 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2004 | 4650 | 0.020 |
Why?
|
| Indocyanine Green | 3 | 1978 | 233 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 384 | 0.020 |
Why?
|
| Calcium Sulfate | 1 | 2007 | 24 | 0.020 |
Why?
|
| Skull | 1 | 2012 | 818 | 0.020 |
Why?
|
| Phosphorus | 1 | 1988 | 336 | 0.020 |
Why?
|
| Amino Acids | 3 | 1978 | 1718 | 0.020 |
Why?
|
| Membrane Potentials | 3 | 1978 | 1090 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 400 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2008 | 2561 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1976 | 1157 | 0.020 |
Why?
|
| Calcium Oxalate | 1 | 2007 | 75 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1986 | 67 | 0.020 |
Why?
|
| Sepsis | 2 | 1977 | 2585 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2004 | 11526 | 0.020 |
Why?
|
| Pentetic Acid | 1 | 1986 | 209 | 0.020 |
Why?
|
| Suppuration | 1 | 1985 | 61 | 0.020 |
Why?
|
| Lasers | 1 | 2010 | 951 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1991 | 1094 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 1091 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 1988 | 655 | 0.020 |
Why?
|
| Incidence | 3 | 2012 | 21341 | 0.020 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 162 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 4638 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 988 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2020 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 16979 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1991 | 946 | 0.010 |
Why?
|
| Thymidine | 1 | 2004 | 299 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 1992 | 1088 | 0.010 |
Why?
|
| Cystoscopy | 1 | 2004 | 131 | 0.010 |
Why?
|
| Materials Testing | 1 | 2007 | 863 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1992 | 1297 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2008 | 8633 | 0.010 |
Why?
|
| Mycobacterium bovis | 1 | 2004 | 147 | 0.010 |
Why?
|
| Collagen Diseases | 1 | 1983 | 39 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 2116 | 0.010 |
Why?
|
| Rupture, Spontaneous | 2 | 1975 | 362 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2008 | 1736 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 2006 | 13337 | 0.010 |
Why?
|
| United States | 3 | 2012 | 72339 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 2 | 1976 | 383 | 0.010 |
Why?
|
| Skin Diseases, Infectious | 1 | 1983 | 76 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1984 | 559 | 0.010 |
Why?
|
| ROC Curve | 1 | 2010 | 3580 | 0.010 |
Why?
|
| Warfarin | 1 | 1991 | 1483 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1988 | 2048 | 0.010 |
Why?
|
| Thigh | 1 | 1983 | 241 | 0.010 |
Why?
|
| Pelvis | 1 | 1986 | 732 | 0.010 |
Why?
|
| p-Aminohippuric Acid | 1 | 1981 | 36 | 0.010 |
Why?
|
| Succimer | 1 | 1981 | 31 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1984 | 1152 | 0.010 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 1981 | 81 | 0.010 |
Why?
|
| Thrombosis | 2 | 1991 | 2942 | 0.010 |
Why?
|
| Urologic Surgical Procedures | 1 | 2004 | 298 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1985 | 1463 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2010 | 2525 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1608 | 0.010 |
Why?
|
| Radiotherapy, Conformal | 1 | 2004 | 548 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1986 | 1626 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1981 | 361 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1991 | 6309 | 0.010 |
Why?
|
| Wounds and Injuries | 2 | 1992 | 2491 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5775 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1980 | 186 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4244 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2005 | 1008 | 0.010 |
Why?
|
| Child, Preschool | 5 | 1992 | 42254 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1992 | 3027 | 0.010 |
Why?
|
| Testis | 1 | 1983 | 794 | 0.010 |
Why?
|
| Cholesteatoma | 1 | 1979 | 28 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3428 | 0.010 |
Why?
|
| Bone Density | 1 | 1992 | 3551 | 0.010 |
Why?
|
| Blood Volume | 1 | 1980 | 548 | 0.010 |
Why?
|
| Toxemia | 1 | 1978 | 14 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 745 | 0.010 |
Why?
|
| Bacteriuria | 1 | 1979 | 102 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 23441 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1978 | 328 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2008 | 1936 | 0.010 |
Why?
|
| Penile Diseases | 1 | 1978 | 45 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 716 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 1650 | 0.010 |
Why?
|
| Homeostasis | 1 | 1989 | 3321 | 0.010 |
Why?
|
| Graft Survival | 1 | 2008 | 3819 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 1599 | 0.010 |
Why?
|
| Lactates | 1 | 1978 | 405 | 0.010 |
Why?
|
| Microsurgery | 1 | 1983 | 795 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5246 | 0.010 |
Why?
|
| Sodium Chloride | 2 | 1972 | 587 | 0.010 |
Why?
|
| Vasculitis | 1 | 1981 | 521 | 0.010 |
Why?
|
| Fats | 1 | 1977 | 99 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 5914 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2000 | 632 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13255 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 2 | 1983 | 1199 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1976 | 169 | 0.010 |
Why?
|
| Rectal Diseases | 1 | 1978 | 143 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3810 | 0.010 |
Why?
|
| Surgical Tape | 1 | 1956 | 4 | 0.010 |
Why?
|
| Diet Therapy | 1 | 1977 | 150 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1976 | 169 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 1978 | 201 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 6132 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1667 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1985 | 1797 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1976 | 698 | 0.010 |
Why?
|
| Hyaline Membrane Disease | 1 | 1975 | 19 | 0.010 |
Why?
|
| Renal Veins | 1 | 1975 | 102 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 2927 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7389 | 0.010 |
Why?
|
| Rabbits | 1 | 1981 | 4779 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1977 | 559 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1161 | 0.010 |
Why?
|
| RNA | 1 | 1984 | 2723 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7595 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6086 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1975 | 104 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1976 | 568 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 1983 | 1490 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1975 | 325 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 13637 | 0.010 |
Why?
|
| Sutures | 1 | 1956 | 284 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1990 | 3425 | 0.010 |
Why?
|
| Loop of Henle | 1 | 1972 | 38 | 0.010 |
Why?
|
| Hernia, Inguinal | 1 | 1956 | 220 | 0.010 |
Why?
|
| Energy Intake | 2 | 1977 | 2134 | 0.010 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1972 | 81 | 0.010 |
Why?
|
| Phenolsulfonphthalein | 1 | 1991 | 3 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22168 | 0.010 |
Why?
|
| Mannitol | 1 | 1972 | 180 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1972 | 230 | 0.010 |
Why?
|
| Ligation | 1 | 1972 | 448 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1978 | 1863 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1975 | 534 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 1971 | 56 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6343 | 0.010 |
Why?
|
| Nephrotic Syndrome | 1 | 1975 | 391 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 3522 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 15717 | 0.010 |
Why?
|
| DNA | 1 | 1984 | 7219 | 0.010 |
Why?
|
| Permeability | 1 | 1972 | 722 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 12938 | 0.010 |
Why?
|
| Insulin | 3 | 1978 | 6602 | 0.010 |
Why?
|
| Iohexol | 1 | 1990 | 204 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 30045 | 0.000 |
Why?
|
| Wilms Tumor | 1 | 1991 | 379 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1991 | 1540 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1990 | 1380 | 0.000 |
Why?
|
| Pressure | 1 | 1990 | 1155 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1991 | 1815 | 0.000 |
Why?
|
| Perfusion | 1 | 1991 | 1373 | 0.000 |
Why?
|
| Wounds, Gunshot | 1 | 1972 | 582 | 0.000 |
Why?
|
| Water | 1 | 1972 | 1410 | 0.000 |
Why?
|
| Sex Factors | 2 | 1983 | 10548 | 0.000 |
Why?
|
| Lung Injury | 1 | 1990 | 422 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10498 | 0.000 |
Why?
|
| Infant | 2 | 1980 | 36205 | 0.000 |
Why?
|
| Cystic Fibrosis | 1 | 1975 | 1286 | 0.000 |
Why?
|
| Renal Artery Obstruction | 1 | 1986 | 219 | 0.000 |
Why?
|
| Hypertension, Renal | 1 | 1985 | 135 | 0.000 |
Why?
|
| Models, Biological | 1 | 1981 | 9469 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1991 | 1299 | 0.000 |
Why?
|
| Bacteria | 1 | 1975 | 2199 | 0.000 |
Why?
|
| Pneumonia | 1 | 1975 | 2140 | 0.000 |
Why?
|
| Renin | 1 | 1985 | 641 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1985 | 574 | 0.000 |
Why?
|
| Digestive System | 1 | 1983 | 244 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 2394 | 0.000 |
Why?
|
| Rectum | 1 | 1986 | 892 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1991 | 1514 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1976 | 4320 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1985 | 1134 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1986 | 1265 | 0.000 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1977 | 304 | 0.000 |
Why?
|
| Typhoid Fever | 1 | 1977 | 194 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1990 | 12330 | 0.000 |
Why?
|
| Debridement | 1 | 1978 | 493 | 0.000 |
Why?
|
| Growth Hormone | 1 | 1977 | 569 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1975 | 26212 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 21012 | 0.000 |
Why?
|
| Muscles | 1 | 1977 | 1576 | 0.000 |
Why?
|
| Dietary Carbohydrates | 1 | 1977 | 891 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1977 | 952 | 0.000 |
Why?
|
| Dietary Fats | 1 | 1977 | 1994 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1977 | 2881 | 0.000 |
Why?
|